Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Aino Health AB (publ) publishes Interim Report 1 July - 30 September 2017

Aino Health AB (publ)
Posted on: 10 Nov 17
Aino Health AB (publ) has published its Interim Report for the third quarter, 1 July - 30 September 2017 today. It is available on the Aino Health website, see also attached pdf-document.

Three important events

- New agreement signed with Finnish construction company Hartela. Aino Healths first agreement within the construction industry.

- A new business model is launched through associated company Maresan Oy, of which Aino Health is a co-founder.

- New service introduced - Business Health index.

  January - September 2017

- Turnover: TSEK 13,505

- Earnings after financial items: TSEK -23,127

- Cash flow: TSEK -22,914

- Earnings per share: SEK -4,3

July - September 2017

- Turnover: TSEK 4,352

- Earnings after financial items: TSEK -9,220

- Cash flow: TSEK -9,714

- Earnings per share: SEK -1,7


Message from the CEO

We have now completed our first nine months as a listed company, and this has been a period of development for us. Through the many rewarding customer meetings we have conducted, we are approaching the major players we want to collaborate with. The signals we are receiving from the market are very positive, and external events indicate that we are getting closer to a breakthrough.

From my perspective, the key to taking the next step in our development is to reach out to the management teams of the major companies we want to have as customers - by building credibility. By credibility, I mean that we have an in-depth understanding of the customer's world and the challenges they face. We have made great progress with this during the quarter, which is exactly why our pipeline in Sweden and Germany is growing with an increasing number of industrial and service companies and actors within the public sector.

The customers we work with today have understood the importance of putting the best interests of both the company and the individual in focus - and the connection between the two. We have made our services and solutions easier to grasp, by clearly showing what they will provide in terms of increased productivity and reduced expenses. We can also assess employee satisfaction with measurable targets. We have been able to back these up with facts and figures linked to the company's own accounts.

We are seeing more and more reports from companies, most recently McKinsey*, for example, showing that healthy companies have returns five times higher than those which are not health- oriented. In other words, what was previously not perceived as a determining success factor is now measurable and even more strategically important for business executives - because healthy people build healthy businesses that deliver strong results.

Through the activities and contacts with customers we have had during the third quarter, I am convinced we are on the right track. During the quarter, we have made significant progress, in accordance with our plan, by entering into agreements with the Finnish construction company Hartela - Aino Health's first agreement within the construction industry - and the infrastructure company Destia, which will utilise our combined Corporate Health Management offering. In addition, an agreement has been entered into with a Finnish subsidiary of a European player in metal production. During the period, we also introduced the innovative Business Health index (BHi) tool, initially in the Finnish market, where agreements for the offering have already been entered into with Stora Enso and Evira. The BHi intiative is further described later in this report.

During the fourth quarter, we will build on the positive trend we have set in the third quarter with implemented sales activities and a three-fold increased pipeline with potential customers. When we later summarise the year, we will be able to show that our unique services deliver expected results for our customers, and the investments we have made during the year in technology development and personnel have been the right decision. More importantly, we have achieved sustainable growth, showing potential customers that Aino has a solutions portfolio, comprising knowledge and a digital platform, which will continue to grow and be a good investment for investors and customers alike.

We are getting increasingly closer to the breakthrough where our current sales efforts will yield the anticipated results. The companies we are in discussions with today are major, well-known and respected brands. I am convinced that when we sign our first major contract, growth will quickly follow.

Jyrki Eklund

CEO Aino Health AB 

* McKinsey Quarterly, April 2014: "The hidden value of organizational health - and how to capture it." By Aaron De Smet, Bill Schaninger, and Matthew Smith.

This information is such information that Aino Health AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set below, at 10 November, 2017 at 08:30 CET.

For more information, please contact:

Jyrki Eklund, CEO Aino Health

Tel: +358 40 042 4221. E-mail: jyrki.eklund@ainohealth.com

www.ainohealth.com

About Aino Health

Aino Health is the leading solution provider in Corporate Health Management; we are for private and public organisations what doctors are for people. The companys complete system of IT-based services reduces sick leave, related costs and deliver long term prosperity, increased productivity and employee engagement by adopting health, wellbeing and safety as an everyday activity.

Aino Health AB (publ) is listed at Nasdaq Stockholm First North (Ticker: AINO). Erik Penser AB, +46 8 463 83 00, is the Certified Advisor to the company.

Aino Health Interim Report Q3 2017_eng
Press release Aino Health Interim Report Q3 2017


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Aino Health AB (publ) via GlobeNewswire
HUG#2148768
GlobeNewswire
globenewswire.com

Last updated on: 11/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.